Exame magazine award 2016

Tecnimede wins award for best company in its Sector


The Tecnimede Group was distinguished by Exame magazine as the best pharmaceutical company in its "500 Greatest and Best of 2016" issue.

The magazine ranks the Tecnimede Group as the pharmaceutical company with the highest profit growth, the second-highest assets profitability, the third-largest growth in sales and the best solvency ratio. The reason for this growth lies in the launches of new products in Portugal and in the international markets, enabling the group to take its net result in 2015 up to 135 million euros when considering all of Tecnimede’s business units.

The group’s investment in research and development needs to be mentioned as well as Tecnimede will channel 15% of its revenues and invest five million euros until 2018 in adaptations in its drug packaging area.